CAPRICOR THERAPEUTICS, INC. — Director's Dealing 2012

Apr 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nile Therapeutics, Inc. (NLTX)
CIK: 0001133869
Period of Report: 2012-03-30

Reporting Person: Kazam Joshua A (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-30	Common Stock	P	125000	—	Acquired	1453228	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-30	Warrant (Right to Buy)	$.50	P	93750	Acquired		Common Stock (93750)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	613841	Indirect
Common Stock	165530	Indirect
Common Stock	165530	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.50	2018-01-25	Common Stock (50000)	50000	Direct
Stock Option (Right to Buy)	$.93	2018-12-22	Common Stock (25000)	25000	Direct
Stock Option (Right to Buy)	$1.77	2019-07-21	Common Stock (65000)	65000	Direct
Stock Option (Right to Buy)	$.37	2020-07-26	Common Stock (80000)	80000	Direct
Stock Option (Right to Buy)	$.73	2021-05-10	Common Stock (80000)	80000	Direct
Warrant (Right to Buy)	$1.25	2014-07-07	Common Stock (49407)	49407	Direct
Warrant (Right to Buy)	$1.71	2014-07-07	Common Stock (49407)	49407	Direct
Warrant (Right to Buy)	$2.28	2014-07-07	Common Stock (98814)	98814	Direct
Warrant (Right to Buy)	$.94	2015-04-21	Common Stock (15000)	15000	Direct
Warrant (Right to Buy)	$1.375	2019-07-15	Common Stock (31650)	31650	Direct

Footnotes

F1: The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.

F2: Held by Reporting Person's spouse as custodian for the benefit of their minor child under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary intrest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.

F3: The Reporting Person is the Trustee of the Kash Family Foundation and controls the right to vote and dispose of the shares held by the Trust. However, the Reporting Person has no pecuniary interest in the shares held by the Foundation.

F4: Fully exercisable.

F5: The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.